NRX Pharmaceuticals
NRXP
NRXP
31 hedge funds and large institutions have $1.76M invested in NRX Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
9
Closed
3
Calls
$41K
Puts
$5K
Net Calls
+$36K
Net Calls Change
-$22K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $232 | -$7.73K | -1,632 | -97% |
|
|
LFG
27
Larson Financial Group
St Louis,
Missouri
| $103 | – | – | – |
|
28
Qube Research & Technologies (QRT)
London,
United Kingdom
| $78 | – | – | – |
|
29
Fidelity Investments
Boston,
Massachusetts
| $52 | +$52 | +11 | New |
|
|
HAG
30
HighPoint Advisor Group
Downers Grove,
Illinois
| – | -$23K | -4,350 | Closed |
|
|
HSA
31
HBK Sorce Advisory
Erie,
Pennsylvania
| – | -$13.4K | -2,923 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$34 | -7 | Closed |
|